Global Albumin Market is projected to surge ahead at a CAGR of 7.9% from 2023 to 2030
Market Overview:
The Global Albumin Market size is expected to grow from USD 5.57 billion in 2022 to USD 9.48 billion by 2030, at a CAGR of 7.9% during the forecast period (2023-2030).
Albumin is a protein found in the blood plasma that plays a crucial role in maintaining the body's fluid balance and transporting various substances, such as hormones, drugs, and fatty acids. It's primarily produced by the liver and contributes significantly to the regulation of osmotic pressure in the blood, helping to prevent fluid from leaking out of blood vessels. Due to its properties, albumin has diverse applications in medicine and research. In the medical field, albumin is commonly used as a plasma expander to treat conditions like hypovolemia (low blood volume) or shock. Its ability to increase blood volume swiftly makes it valuable in emergency situations. Additionally, albumin finds application in drug delivery systems, stabilizing and delivering medications. In research, it serves as a standard protein for various biochemical studies, including electrophoresis and protein assays.
Key Players For The Global Albumin Market:
Albumedix Ltd. (UK), Albumin Bioscience (US), Biotest AG (Germany), CSL Behring (US), Grifols International SA (Spain), HiMedia Laboratories Pvt. Ltd. (India), InVitria (US), Medxbio Pte. Ltd. (Singapore), MilliporeSigma (US), Octapharma AG (Switzerland), RayBiotech Inc. (Georgia), Seracare Life Sciences Inc. (the US), Akron Biotech (US), Bristol-Myers Squibb Company (US)
Acquire PDF Sample Report + All Related thorough TOC, Graphs and Tables of Global Market Now:
https://introspectivemarke...
Introspective Market Research provide comprehensive market research studies, delivering valuable insights and strategic guidance to businesses worldwide. Our operations are driven by accurate analysis and extensive coverage of all the areas
Market Overview:
The Global Albumin Market size is expected to grow from USD 5.57 billion in 2022 to USD 9.48 billion by 2030, at a CAGR of 7.9% during the forecast period (2023-2030).
Albumin is a protein found in the blood plasma that plays a crucial role in maintaining the body's fluid balance and transporting various substances, such as hormones, drugs, and fatty acids. It's primarily produced by the liver and contributes significantly to the regulation of osmotic pressure in the blood, helping to prevent fluid from leaking out of blood vessels. Due to its properties, albumin has diverse applications in medicine and research. In the medical field, albumin is commonly used as a plasma expander to treat conditions like hypovolemia (low blood volume) or shock. Its ability to increase blood volume swiftly makes it valuable in emergency situations. Additionally, albumin finds application in drug delivery systems, stabilizing and delivering medications. In research, it serves as a standard protein for various biochemical studies, including electrophoresis and protein assays.
Key Players For The Global Albumin Market:
Albumedix Ltd. (UK), Albumin Bioscience (US), Biotest AG (Germany), CSL Behring (US), Grifols International SA (Spain), HiMedia Laboratories Pvt. Ltd. (India), InVitria (US), Medxbio Pte. Ltd. (Singapore), MilliporeSigma (US), Octapharma AG (Switzerland), RayBiotech Inc. (Georgia), Seracare Life Sciences Inc. (the US), Akron Biotech (US), Bristol-Myers Squibb Company (US)
Acquire PDF Sample Report + All Related thorough TOC, Graphs and Tables of Global Market Now:
https://introspectivemarke...
Introspective Market Research provide comprehensive market research studies, delivering valuable insights and strategic guidance to businesses worldwide. Our operations are driven by accurate analysis and extensive coverage of all the areas
8 months ago
